Effect of carnitine supplementation in treatment of women with polycystic ovary syndrome

Not Applicable

• Conditions: Polycystic ovary syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT2017070433941N3
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Patients with polycystic ovary syndrome according to Rotterdam criteria
Aged 18 to 40 years

Exclusion Criteria

Pregnant women
Elevated levels of prolactin
Endocrine diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean left CIMT. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Sonography.;Maximum left CIMT. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Sonography.;Mean right CIMT. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Sonography.;Maximum right CIMT. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Sonography.

Secondary Outcome Measures

Name	Time	Method
Hs-CRP. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Nitric oxide. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Spectrophotometry.